RJK Explorations Ltd. Announces Private Placement for Gross Proceeds of up to $100,000
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR
NORTHAMPTON, MA / ACCESS Newswire / August 11, 2026 / Marathon Petroleum’s Mia Lombardi takes
NORTHAMPTON, MA / ACCESS Newswire / August 11, 2026 / Marathon Petroleum’s Mia Lombardi takes
Doubles Fermi power to market to 4.8 gigawatts (GW) over the next ~30 months Build-Own-Operate-Transfer
Doubles Fermi power to market to 4.8 gigawatts (GW) over the next ~30 months Build-Own-Operate-Transfer
GREENWICH, Conn. and AUSTIN, Texas and LOS ANGELES, Aug. 11, 2026 /PRNewswire/ — Generation Partners
PORTLAND, Ore., Aug. 11, 2026 /PRNewswire/ — Pixelworks, Inc. (NASDAQ: PXLW) (“Pixelworks” or the “Company”),
Portfolio Includes 250 Granted Patents and Contributions to the International VVC Video Compression Standard BOCA
Order supports enterprise deployments across warehousing, logistics and field service applications with Vuzix M400 and
Claiming first championship following last year’s third-place finish, solving all challenges within 25 hours of
Inc. 5000 Recognition Reflects Growing Demand for Clearview AI’s Public Safety Technology Its Leadership in
HONG KONG, Aug. 11, 2026 /PRNewswire/ — China Literature Limited (“China Literature” or “the Company”,
LITTLE ELM, TX / ACCESS Newswire / August 11, 2026 / As the demand for
Hemogenyx Pharmaceuticals Signs Definitive Collaboration Agreement with Cellin Technologies for Manufacturing and Commercialization of HG-CT-1
LONDON, UK / ACCESS Newswire / August 11, 2026 / The Company announces that on
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY
New leaderboard and evidence features let marketing and communications teams track visibility against named competitors
Consumer Education Campaign Reminds Drivers That Tire Condition is One of the Most Important Factors
SAN DIEGO, CA / ACCESS Newswire / August 10, 2026 / CV Sciences, Inc. (OTCQB:CVSI)
After eight years, more than $10 million in pharmaceutical development and cannabinoid capsules manufactured by